Retraction Note: J Exp Clin Cancer Res 39, 146 (2020)
https://doi.org/10.1186/s13046-020-01654-3
The Editor-in-Chief has retracted this article. After publication concerns were raised with respect to the overlap of figures with a previously published article from another author group [1]. Specifically:
-
Figure 1b, 1c, 1d, 1e and 1f with Figure 1c, 1d, 1e, 1f and 1h of Figure 1 of [1]
-
Figure 2 with Figure 2 of [1]
-
Figure 3b and 3c with Figure 3b and 3d of [1]
-
Figure 4b, 4c and 4d with Figure 4b, 4c and 4d of [1]
-
Figure 5 with Figure 5 of [1]
-
Figure 6 with Figure 6 of [1]
-
Figure 7 with Figure 7 of [1]
The Editor-in-Chief no longer has confidence in the results and conclusions reported. Ming Hong agrees with this retraction. Jacob Clayton, Wildman Yake and Jinke Li have not responded to correspondence from the Publisher about this retraction. The Publisher was not able to obtain a current email address for Selena Lee.
Reference
Zhang T, Li J, Yin F, et al. Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3. Oncogene. 2017;36:6627–39.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Hong, M., Lee, S., Clayton, J. et al. Retraction Note: Genipin suppression of growth and metastasis in hepatocellular carcinoma through blocking activation of STAT-3. J Exp Clin Cancer Res 41, 102 (2022). https://doi.org/10.1186/s13046-022-02308-2
Published:
DOI: https://doi.org/10.1186/s13046-022-02308-2